Pharmacological interaction between LABAs and LAMAs in the airways: optimizing synergy
L Calzetta, MG Matera, M Cazzola - European journal of pharmacology, 2015 - Elsevier
Nowadays there is solid clinical information for combining β 2-agonists and anti-muscarinic
agents, although the nature (additive or synergistic) of the net clinical result obtained by co …
agents, although the nature (additive or synergistic) of the net clinical result obtained by co …
Pharmacological interaction between LABAs and LAMAs in the airways: Optimizing synergy
L Calzetta, MG Matera, M Cazzola - EUROPEAN JOURNAL OF …, 2015 - iris.unicampania.it
Nowadays there is solid clinical information for combining β 2-agonists and anti-muscarinic
agents, although the nature (additive or synergistic) of the net clinical result obtained by co …
agents, although the nature (additive or synergistic) of the net clinical result obtained by co …
[引用][C] Pharmacological interaction between LABAs and LAMAs in the airways: optimizing synergy
L Calzetta, M Matera, M Cazzola - EUROPEAN JOURNAL OF …, 2015 - air.unipr.it
Pharmacological interaction between LABAs and LAMAs in the airways: optimizing synergy
IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano Italiano …
IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano Italiano …
Pharmacological interaction between LABAs and LAMAs in the airways: optimizing synergy.
L Calzetta, MG Matera, M Cazzola - European Journal of …, 2015 - europepmc.org
Nowadays there is solid clinical information for combining β2-agonists and anti-muscarinic
agents, although the nature (additive or synergistic) of the net clinical result obtained by co …
agents, although the nature (additive or synergistic) of the net clinical result obtained by co …
Pharmacological interaction between LABAs and LAMAs in the airways: optimizing synergy
L Calzetta, MG Matera… - European journal of …, 2015 - pubmed.ncbi.nlm.nih.gov
Nowadays there is solid clinical information for combining β2-agonists and anti-muscarinic
agents, although the nature (additive or synergistic) of the net clinical result obtained by co …
agents, although the nature (additive or synergistic) of the net clinical result obtained by co …
Pharmacological interaction between LABAs and LAMAs in the airways: optimizing synergy
L Calzetta, MG Matera, M Cazzola - European Journal of Pharmacology, 2015 - infona.pl
Nowadays there is solid clinical information for combining β2-agonists and anti-muscarinic
agents, although the nature (additive or synergistic) of the net clinical result obtained by co …
agents, although the nature (additive or synergistic) of the net clinical result obtained by co …